Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Nicole Malachowski ’s post on LinkedIn about recent article by Marwa Omar et al., published in International Journal of Molecular Sciences, adding:
“NETosis is often described as being a ‘double-edged sword’, often used to describe situations where it has the potential for both positive and negative impacts on the host when combating and trying to recover from infectious insults.
Santersus AG has decided to offer a unique and very promising treatment for ‘NETosis dysregulation’ that helps patients remove tissue-damaging NETs from the blood circulation rather than interfering with the NETotic response via systemic drug administration, which can create unwanted side effects and reduce the efficacy of site-specific innate NETosis and NET removal/clearance where it is needed.
‘Most of the studies that have addressed the implications of NETs in protozoan infections have chiefly focused on their protective side, either through trapping or killing.
Challenging this belief, we propose several limitations regarding protozoan-NETs interaction.
One of many is the duality in the functional responses of NETs, in which both the positive and pathological aspects seem to be closely”
Nicole Malachowski, shared a post on LinkedIn:
“ICYMI: A new study came out last week, and it is huge.
FDA-cleared Lyme disease tests have been missing up to 78% of early Lyme cases.
It’s worse than we could have imagined.
How many people are being misdiagnosed?
How much chronic illness has developed because of this?
How much unnecessary suffering has been caused for patients and families?
We need improved diagnostics now.
Read the details from the Bay Area Lyme Foundation here:”
Title: NETosis in Parasitic Infections: A Puzzle That Remains Unsolved
Authors: Marwa Omar, Heba Abdelal
Stay updated on all scientific advances Hemostasis Today.
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026